MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adia Nutrition Inc (OP:ADIA)

0.1310 UNCHANGED
Streaming Delayed Price Updated: 3:45 PM EDT, Jun 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.1310
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1310
Today's Range 0.1310 - 0.1310
52wk Range 0.0227 - 0.2777
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Adia Med Improves Quality of Care with Advanced Ultrasound-Guided IV Training
Winter Park, Florida--(Newsfile Corp. - June 16, 2026) - Adia Med, the regenerative medicine and advanced IV therapy division of... 
Via Newsfile
News headline image
Adia Nutrition Inc. Delivers Exciting Update: Name Change to Adia Med Inc. Now Official in Nevada
Winter Park, Florida--(Newsfile Corp. - June 10, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is pleased to confirm that the... 
Via Newsfile

Performance

YTD
+87.1%
+87.1%
1 Month
-15.5%
-15.5%
3 Month
+9.2%
+9.2%
6 Month
+67.9%
+67.9%
1 Year
+162.0%
+162.0%

More News

Read More
News headline image
Adia Nutrition Launches Dynamic New Subsidiary ADIA Life LLC in Florida to Supercharge Distribution and Unlock a Full Spectrum of Life-Transforming Wellness Solutions
Via Newsfile
News headline image
Adia Nutrition, Inc. Drops Explosive Sneak Peek of Upcoming Documentary Featuring TNA Wrestling Star Jeff Sciullo (Elias)
Via Newsfile
News headline image
Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry
Via Newsfile
News headline image
Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov
Via Newsfile
News headline image
ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026
Via Newsfile
News headline image
ADIA Nutrition Announces IRB Approval of All Four Clinical Studies and Registration of Kidney Health Study on ClinicalTrials.gov
Via Newsfile
News headline image
Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)
Via Newsfile
News headline image
Adia Nutrition Announces Three Pivotal Clinical Studies Receive Major IRB Milestone - Final Approval Now Clearly in Sight
Via Newsfile
News headline image
Adia Nutrition, Inc. Looking to Acquire Larger Property to Expand Flagship Clinic in Winter Park, Reports Strong Operational Momentum in Q1 2026 and Provides Optimistic Outlook for Remainder of the Year
Via Newsfile
Topics Regulatory Compliance Supply Chain
News headline image
Adia Nutrition, Inc. Announces Corporate Name Change to Adia Med, Inc. to Better Align with Its Regenerative Medicine and Biologics Business Model
Via Newsfile
Topics Regulatory Compliance
News headline image
Undervalued OTC Stocks Radar: ADMQ, ADIA, RDTCF, BFGFF, ROKRF Gaining Investor Attention in 2026
Via AB Newswire
News headline image
Adia Nutrition Strikes Major Partnership with Leading Atlanta Clinic to Launch Groundbreaking Autism Clinical Study
Via Newsfile
Topics Supply Chain
Small Caps, Big Potential: Regenerative Medicine Stocks Positioned for Growth (ADIA, FATE, MESO, CRSP)
Via AB Newswire
Four Rising Stars Driving the Next Wave of Stem Cell and Gene Therapy Innovation (AIDA, MESO, LCTX, CRSP)
Via AB Newswire
News headline image
Four Rising Stars Driving the Next Wave of Stem Cell and Gene Therapy Innovation
Via News Direct
News headline image
Adia Nutrition Inc. to Present at the Life Sciences Virtual Investor Forum June 11th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Sciences Investor Forum: Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
4 Stocks To Watch In The $47 Billion Cellular Therapeutics Market
Via News Direct
Topics Derivatives Regulatory Compliance
4 Stocks Poised to Thrive in the $47 Billion Cell Therapeutics Market
Via AB Newswire
Topics Derivatives Regulatory Compliance
News headline image
Life Sciences Investor Forum Agenda Announced for June 11th-12th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Stem Cell Innovators: 4 Companies Advancing Regenerative Medicine
Via AB Newswire
News headline image
Stem Cell Innovators: 4 Companies Advancing Regenerative Medicine
Via News Direct
News headline image
Stem Cell Stocks on the Rise: Companies Driving the $48 Billion Market Boom
Via AB Newswire

Frequently Asked Questions

Is Adia Nutrition Inc publicly traded?
Yes, Adia Nutrition Inc is publicly traded.
What exchange does Adia Nutrition Inc trade on?
Adia Nutrition Inc trades on the OTC Traded
What is the ticker symbol for Adia Nutrition Inc?
The ticker symbol for Adia Nutrition Inc is ADIA on the OTC Traded
What is the current price of Adia Nutrition Inc?
The current price of Adia Nutrition Inc is 0.1310
When was Adia Nutrition Inc last traded?
The last trade of Adia Nutrition Inc was at 06/23/26 03:45 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story